Symetis Adds Transfemoral TAVR Offering In Europe

The Swiss company says it is the only company other than Edwards Lifesciences and Medtronic to offer both transapical and transfemoral options for transcatheter aortic heart valve delivery.

Symetis SA announced the European launch of its Acurate neo transfemoral transcatheter aortic valve replacement system, which earned a CE mark this summer, on Sept. 11.

Acurate neo joins Symetis’ Acurate TA transapically delivered TAVR system on the European market. That makes Symetis the only company...

More from Archive

More from Medtech Insight